Authors: Napoli, C.¹; Sica, V.²; Pignalosa, O.³; Nigris, F. d.⁴

Source: Current Medicinal Chemistry, Volume 12, Number 15, July 2005 , pp. 1755-1772(18)

Publisher: Bentham Science Publishers

Abstract:

New approaches to atherosclerosis-related diseases include novel uses of proven treatments and development of innovative agents. Several commonly used cardiovascular drugs such as dihydropyridine calcium antagonists, ACE inhibitors containing the sulphydryl group, or highly lipophilic beta-blockers have some antiatherosclerotic activities. Moreover, new clinical trials suggesting that additional reduction of lowdensity lipoprotein cholesterol levels with statin therapy results in additional benefit in coronary heart disease prevention. Notably, new cholesterol transport or bile acid transport inhibitors have been found to produce significant reductions in intestinal cholesterol absorption and experimental atherosclerosis. Inhibitors of acyl coenzyme A:cholesterol acyltransferase, which can reduce cholesterol storage in macrophages and in arterial lesions, have also been developed. Finally, newer therapeutical strategies against atherogenesis may include the use of antioxidants and cholestyramine during pregnancy or the development of metalloproteinase inhibitors.

Keywords: atherosclerosis; statins; ace-inhibitors; antioxidants

Document Type: Review article

DOI: http://dx.doi.org/10.2174/0929867054367257

Affiliations: 1: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0 2: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0 3: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0 4: Department of General Pathology, School of Medicine, Via L. De Crecchio, 7, II University of Naples, Naples 80134, Italy or at the Evans Department of medicine and Whitaker Cardiovascular Institute, Boston University, 715 Albany St., Boston, MA 0

Publication date: 2005-07-01

More about this publication?

• Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Napoli, C. ;  Sica, V. ;  Pignalosa, O. ;  Nigris, F. d.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers